Items where Author is "Furrer, H."

2017

Gebreselassie, H. M. and Kraus, D. and Fux, C. A. and Haubitz, S. and Scherrer, A. and Hatz, C. and Veit, O. and Stoeckle, M. and Fehr, J. and de Lucia, S. and Cavassini, M. and Bernasconi, E. and Schmid, P. and Furrer, H. and Staehelin, C. and Swiss HIV Cohort Study, . (2017) Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study. HIV Medicine, 18 (8). pp. 564-572.

2015

Schlagenhauf, P. and Hatz, C. and Behrens, R. and Visser, L. and Funk, M. and Holzer, B. and Beck, B. and Bourquin, C. and Etter, H. and Furrer, H. and Genton, B. and Landry, P. and Chappuis, F. and Loutan, L. and Stossel, U. and Jeschko, E. and Rossano, A. and Nothdurft, H. D.. (2015) Mefloquine at the crossroads? : Implications for malaria prophylaxis in Europa. Travel medicine and infectious disease, Vol. 13, H. 2. pp. 192-196.

2013

Furrer, H. and Staehelin, C. and Landolt, R. and Hatz, C.. (2013) Reisemedizinische Beratung : mehr als eine Impfcheckliste. Therapeutische Umschau : Monatsschrift für praktische Medizin, Bd. 70, H. 6. pp. 309-312.

Beerenwinkel, N. and Montazeri, H. and Schuhmacher, H. and Knupfer, P. and von Wyl, V. and Furrer, H. and Battegay, M. and Hirschel, B. and Cavassini, M. and Vernazza, P. and Bernasconi, E. and Yerly, S. and Boni, J. and Klimkait, T. and Cellerai, C. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2013) The Individualized Genetic Barrier Predicts Treatment Response in a Large Cohort of HIV-1 Infected Patients. PLoS Computational Biology, Vol. 9, H. 8 , e1003203.

2012

Fenner, L. and Egger, M. and Bodmer, T. and Altpeter, E. and Zwahlen, M. and Jaton, K. and Pfyffer, G. E. and Borrell, S. and Dubuis, O. and Bruderer, T. and Siegrist, H. H. and Furrer, H. and Calmy, A. and Fehr, J. and Stalder, J. M. and Ninet, B. and Bottger, E. C. and Gagneux, S.. (2012) Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, Vol. 56, H. 6. pp. 3047-3053.

Scherrer, A. U. and Boni, J. and Yerly, S. and Klimkait, T. and Aubert, V. and Furrer, H. and Calmy, A. and Cavassini, M. and Elzi, L. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Gunthard, H. F. and Swiss HIV Cohort Study Shcs, . (2012) Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens. PLoS one, Vol. 7, H. 11 , e50307.

Scherrer, A. U. and Ledergerber, B. and von Wyl, V. and Boni, J. and Yerly, S. and Klimkait, T. and Cellerai, C. and Furrer, H. and Calmy, A. and Cavassini, M. and Elzi, L. and Vernazza, P. L. and Bernasconi, E. and Gunthard, H. F. and Swiss HIV Cohort Study Shcs, . (2012) Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients. PLoS one, Vol. 7, H. 6 , e37983.

Fenner, L. and Gagneux, S. and Helbling, P. and Battegay, M. and Rieder, H. L. and Pfyffer, G. E. and Zwahlen, M. and Furrer, H. and Siegrist, H. H. and Fehr, J. and Dolina, M. and Calmy, A. and Stucki, D. and Jaton, K. and Janssens, J. P. and Stalder, J. M. and Bodmer, T. and Ninet, B. and Böttger, E. C. and Egger, M.. (2012) Mycobacterium tuberculosis transmission in a country with low tuberculosis incidence : role of immigration and HIV infection. Journal of clinical microbiology, Vol. 50, H. 2. pp. 388-395.

Thierfelder, C. and Weber, R. and Elzi, L. and Furrer, H. and Cavassini, M. and Calmy, A. and Bernasconi, E. and Gutmann, C. and Ledergerber, B. and Swiss HIV Cohort Study Group, . (2012) Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study. HIV medicine, Vol. 13. pp. 118-126.

2011

El Amari, E. Boffi and Combescure, C. and Yerly, S. and Calmy, A. and Kaiser, L. and Hasse, B. and Furrer, H. and Cavassini, M. and Vernazza, P. and Hirsch, Hh and Bernasconi, E. and Hirschel, B. and Swiss HIV Cohort Study, . (2011) Clinical relevance of cytomegalovirus viraemia(*,†). HIV medicine, Vol. 12, H. 7. pp. 394-402.

Schüpbach, Jörg and Bisset, Leslie R. and Regenass, Stephan and Bürgisser, Philippe and Gorgievski, Meri and Steffen, Ingrid and Andreutti, Corinne and Martinetti, Gladys and Shah, Cyril and Yerly, Sabine and Klimkait, Thomas and Gebhardt, Martin and Schöni-Affolter, Franziska and Rickenbach, Martin and Swiss HIV Cohort Study, and Barth, J. and Battegay, M. and Bernascon, E. and Böni, J. and Bucher, H. C. and Bürgisser, P. and Burton-Jeangros, C. and Calmy, A. and Cavassini, M. and Dubs, R. and Egger, M. and Elzi, L. and Fehr, J. and Fischer, M. and Flepp, M. and Francioli, P. and Furrer, H. and Fux, C. A. and Gorgievski, M. and Günthard, H. and Hasse, B. and Hirsch, H. H. and Hirschel, B. and Hösli, I. and Kahlert, C. and Kaiser, L. and Keiser, O. and Kind, C. and Klimkait, T. and Kovari, H. and Ledergerber, B. and Martinetti, G. and Martinez de Tejada, B. and Müller, N. and Nadal, D. and Pantaleo, G. and Rauch, A. and Regenass, S. and Rickenbach, M. and Rudin, C. and Schmid, P. and Schultze, D. and Schöni-Affolter, F. and Schüpbach, J. and Speck, R. and Taffé, P. and Telenti, A. and Trkola, A. and Vernazza, P. and von Wyl, V. and Weber, R. and Yerly, S.. (2011) High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease. BMC infectious diseases, Vol. 11 , 254. p. 254.

Mossdorf, E. and Stöckle, M. and Mwaigomole, E. G. and Chiweka, E. and Kibatala, P. L. and Geubbels, E. and Urassa, H. and Abdulla, S. and Elzi, L. and Tanner, M. and Furrer, H. and Hatz, C. and Battegay, M.. (2011) Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition. BMC infectious diseases, Vol. 11 , 98.

Ledergerber, B. and Cavassini, M. and Battegay, M. and Bernasconi, E. and Vernazza, P. and Hirschel, B. and Furrer, H. and Rickenbach, M. and Weber, R. and Swiss HIV Cohort Study, . (2011) Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study. HIV medicine, Vol. 12, H. 5. pp. 279-288.

2010

Franceschi, S. and Lise, M. and Clifford, G. M. and Rickenbach, M. and Levi, F. and Maspoli, M. and Bouchardy, C. and Dehler, S. and Jundt, G. and Ess, S. and Bordoni, A. and Konzelmann, I. and Frick, H. and Dal Maso, L. and Elzi, L. and Furrer, H. and Calmy, A. and Cavassini, M. and Ledergerber, B. and Keiser, O. and Swiss HIV Cohort Study, . (2010) Changing patterns of cancer incidence in the early- and late-HAART periods : the Swiss HIV Cohort Study. British journal of cancer, Vol. 103, no. 3. pp. 416-422.

2009

Combescure, Christophe and Vallier, N. and Ledergerber, B. and Cavassini, M. and Furrer, H. and Rauch, A. and Battegay, M. and Bernasconi, E. and Vernazza, P. and Hirschel, B.. (2009) How reliable is an undetectable viral load? HIV medicine : the official journal of the British HIV Association (BHIVA) and the European AIDS Clinical Society (EACS), Vol. 10. pp. 470-476.

Veit, O. and Niedrig, M. and Chapuis-Taillard C., and Cavassini, M. and Mossdorf, E. and Schmid, P. and Bae, H. G. and Litzba, N. and Staub, T. and Hatz, C. and Furrer, H.. (2009) Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients. Clinical Infectious Diseases, Vol. 48, H. 5. pp. 659-666.

2008

Wunder, D. M. and Fux, C. A. and Bersinger, N. A. and Mueller, N. J. and Hirschel, B. and Cavassini, M. and Elzi, L. and Schmid, P. and Bernasconi, E. and Mueller, B. and Furrer, H. and Swiss, HIV Cohort Study. (2008) Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy : a case-control study. HIV medicine, Vol. 9. pp. 427-432.

Khanna, N. and Opravil, M. and Furrer, H. and Cavassini, M. and Vernazza, P. and Bernasconi, E. and Weber, R. and Hirschel, B. and Battegay, M. and Kaufmann, G. R. and Swiss, HIV Cohort Study. (2008) CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clinical Infectious Diseases, Vol. 47. pp. 1093-1101.

Wolbers, M. and Bucher, H. C. and Furrer, H. and Rickenbach, M. and Cavassini, M. and Weber, R. and Schmid, P. and Bernasconi, E. and Hirschel, B. and Battegay, M. and Swiss, HIV Cohort Study. (2008) Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV medicine, Vol. 9. pp. 397-405.

Vo, T. T. and Ledergerber, B. and Keiser, O. and Hirschel, B. and Furrer, H. and Battegay, M. and Cavassini, M. and Bernasconi, E. and Vernazza, P. and Weber, R. and Swiss, HIV Cohort Study. (2008) Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study. Journal of Infectious Diseases, Vol. 197, no. 12. pp. 1685-1694.

von Wyl, V. and Yerly, S. and Böni, J. and Bürgisser, P. and Klimkait, T. and Battegay, M. and Bernasconi, E. and Cavassini, M. and Furrer, H. and Hirschel, B. and Vernazza, P. L. and Rickenbach, M. and Ledergerber, B. and Günthard, H. F. and Swiss, HIV Cohort Study. (2008) Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. Clinical Infectious Diseases, Vol. 46. pp. 1299-1309.

Rauch, A. and Nolan, D. and Furrer, H. and McKinnon, E. and John, M. and Mallal, S. and Gaudieri, S. and Günthard, H. F. and Schmid, P. and Battegay, M. and Hirschel, B. and Telenti, A. and James, I. and Swiss, HIV Cohort Study. (2008) HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy. Clinical Infectious Diseases, Vol. 46. pp. 1921-1925.

Polesel, J. and Clifford, G. M. and Rickenbach, M. and Dal Maso, L. and Battegay, M. and Bouchardy, C. and Furrer, H. and Hasse, B. and Levi, F. and Probst-Hensch, N. M. and Schmid, P. and Franceschi, S. and Swiss, HIV Cohort Study. (2008) Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS, Vol. 22. pp. 301-306.

El Amari, E. B. and Toutous-Trellu, L. and Gayet-Ageron, A. and Baumann, M. and Cathomas, G. and Steffen, I. and Erb, P. and Mueller, N. J. and Furrer, H. and Cavassini, M. and Vernazza, P. and Hirsch, H. H. and Bernasconi, E. and Hirschel, B. and Swiss, HIV Cohort Study. (2008) Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. AIDS, Vol. 22. pp. 1019-1028.

Glass, T. R. and De Geest, S. and Hirschel, B. and Battegay, M. and Furrer, H. and Covassini, M. and Vernazza, P. L. and Bernasconi, E. and Rickenboch, M. and Weber, R. and Bucher, H. C. and Swiss, HIV Cohort Study. (2008) Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antiviral therapy, Vol. 13. pp. 77-85.

2004

Zellweger, C. and Opravil, M. and Bernasconi, E. and Cavassini, M. and Bucher, H. C. and Schiffer, V. and Wagels, T. and Flepp, M. and Rickenbach, M. and Furrer, H. and Swiss, H. I. V. Cohort Study. (2004) Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia: prospective multicentre study. AIDS, 18 (15). pp. 2047-2053.